Pacific Biometrics Inc.
220 West Harrison Street
Seattle,
WA 98119
United States - Map
Phone: 206-298-0068
Fax: 206-298-9838
Web Site: http://www.pacbio.com
| Pacific Biometrics, Inc. provides specialty reference and clinical laboratory services primarily to the pharmaceutical, biotechnology, and diagnostics industries in the United States. The companys services support pharmaceutical and laboratory diagnostic manufacturers in the conduct of human clinical research, for use in drug and diagnostic product development efforts. Its services include specialty reference laboratory services, including clinical study testing services, development of laboratory reference methods, development of clinical trial protocols, and contract research and development in the areas of cardiovascular disease, diabetes, metabolic syndrome, obesity, and bone and joint diseases. The company also offers central laboratory services for multi-center clinical trials that comprise project management and routine safety lab tests. In addition, it provides clinical biomarker services for biomarker assay development, immunogenicity testing, and multiplex testing. The company was founded in 1996 and is based in Seattle, Washington. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Ronald Helm , 58
Exec. Chairman, Chief Exec. Officer, Pres and Chief Exec. Officer of Pacific Biomarkers Inc |
N/A
| N/A | Dr. Elizabeth Teng Leary Ph.D., D.A.B.C.C., 61
Co-Founder and Chief Scientific Officer |
N/A
| N/A | Dr. Michael P. Murphy Ph.D, D.A.B.C.C., 54
Chief Operating Officer |
N/A
| N/A | Mr. John P. Jensen , 53
Prinicipal Financial Officer, Prinicipal Accounting Officer, VP of Fin. and Controller |
N/A
| N/A | Dr. Mario R. Ehlers M.D., Ph.D., 53
Consultant, Director, Pres of Pacific Biomarkers Inc of Pacific Biomarker's Inc |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-09
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.29% Nasdaq 0.00%
Profile
